Name | 3-[(R)-[(2S,5R)-2,5-dimethyl-4-prop-2-enylpiperazin-1-yl]-(3-hydroxyphenyl)methyl]-N-(3-fluorophenyl)-N-methylbenzamide |
---|---|
Synonyms |
unii-r3uo4y068s
dpi-3290 |
Description | DPI-3290 (Org 41793) is a potent and specific opioid receptors agonist with Ki values of 0.18 nM, 0.46 nM, and 0.62 nM for δ-, μ-, and κ-opioid receptors, respectively。DPI-3290 is one of a series of novel centrally acting agents with potent antinociceptive activity[1]. |
---|---|
Related Catalog | |
Target |
IC50: 0.18 nM (δ-opioid receptor), 0.46 nM (μ-opioid receptor) and 0.62 nM (κ-opioid receptor)[1] |
In Vivo | DPI-3290 (Org 41793) (intravenous; 0.05 mg/kg) produces a 50% antinociceptive response in rats[1]. |
References |
Density | 1.161±0.06 g/cm3(Predicted) |
---|---|
Boiling Point | 620.4±55.0 °C(Predicted) |
Melting Point | 144-145 °C |
Molecular Formula | C30H34FN3O2 |
Molecular Weight | 487.60800 |
Exact Mass | 487.26400 |
PSA | 47.02000 |
LogP | 5.35370 |
Storage condition | 2-8°C |